Roche's 2011 MDx Sales Rise 4 Percent as Applied Science Lags | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche today reported 2011 revenue growth of 6 percent at constant exchange rates for its diagnostics division including a 4 percent increase in sales for molecular diagnostic products.

The Swiss drugs, diagnostics, and research products giant reported total diagnostics sales of CHF 9.74 billion ($10.65 billion). Though the firm reported growth at constant exchange rates, in Swiss francs its diagnostics sales were down 7 percent from CHF 10.42 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.